August 6, 2020
TOKYO, August 6, 2020 - PHC Corporation (headquarters: Minato-ku, Tokyo) today announces the launch of the LabAlert PRO*1 Cloud-Based Remote Monitoring System for efficient and convenient monitoring of facilities and equipment used for the pharmaceutical/sample storage in pharmaceutical companies, laboratories, and medical institutions in Japan.
At present, there is a rise in both ongoing drug development research for diverse medical needs, such as vaccines for infectious diseases and specialty pharmaceuticals for cancer and rare diseases, and other research aimed at developing novel advanced therapies, such as cell therapy. These areas of research require more rigorous quality assurance and information management that are compliant with GMP*2 and GDP*3 guidelines, reduced risk by protecting valuable samples from damage caused by inappropriate storage environments, and more efficient monitoring of facilities and equipment used for storing pharmaceuticals/samples at research facilities and medical institutions.
Via the internet, the newly launched LabAlert PRO will connect to life sciences equipment such as ultra-low temperature freezers and CO2 incubators, and to servers storing monitored data and user sites. This cloud-based system monitors the operational status of equipment, such as interior temperatures, CO2 concentration levels, and door opening frequency, and saves the data automatically on a cloud-based server. This minimizes server management tasks such as operating system updates and backing up of data, and also provides real-time remote monitoring of site equipment through mobile devices such as smartphones and tablets. Since there is no limitation*4 on the number of devices or facilities this new product can connect, it flexibly responds to different needs ranging from monitoring specific equipment to centralized management of large-scale facilities with 50+ units of equipment. In addition, connecting with the PHC Corporation’s life sciences equipment allows monitoring and setup adjustments through sensor-free digital connection, helping to reduce contamination risk for research environments.
PHC Corporation is a Japanese subsidiary of the PHC Group, a global healthcare company that develops, manufactures, sells, and services solutions across diabetes management, diagnostics and life sciences, as well as providing healthcare service businesses. The new LabAlert PRO system will expand the portfolio of products in the life sciences business.
Nobuaki Nakamura, Corporate Officer and co-head of Diagnostics/Life Sciences Domain of PHC Holdings Corporation says, “Our life sciences business dates back to 1966 when the company launched our first pharmaceutical refrigerators. Our solutions continue to be acclaimed by our customers for their precise technology and high quality craftsmanship, which has accumulated for more than half a century in this industry. The new LabAlert PRO is a monitoring system that has achieved further convenience and efficiency by adding connected technology using IoT to our precise hardware technology. We believe it will help support more efficient research and development of new therapeutic modalities that demand even more strict quality control. As a company aiming to become the leading provider of best-in-class precision and digital solutions, we are working hard to contribute to the efforts of researchers and healthcare professionals by offering products and services that address the challenges they face.”
*1 Product details: www.phchd.com/jp/biomedical/consumer-products/labalert_pro (Japanese website)
*2 GMP (Good Manufacturing Practice): manufacturing control and quality control standard implemented on manufacturers (including overseas) and distributors.
*3 GDP (Good Distribution Practices): basic guidelines for ensuring the quality of pharmaceuticals throughout the supply chain including shipment from manufacturing plant and until they reach the end user.
*4 There may be a limit on the number of connections depending on the installment conditions of the life sciences equipment.
About PHC Holdings Corporation
Incorporated in 2014, PHC Holdings Corporation is a global healthcare company with subsidiaries including PHC Corporation, Ascensia Diabetes Care Holdings AG, Epredia, and LSI Medience Corporation. Committed to its corporate mission, “We contribute to the health of society through our diligent efforts to create healthcare solutions that have a positive impact and improve the lives of people,” the company develops, manufactures, sells and services solutions across diabetes management, diagnostics, life sciences and healthcare services, which are available in more than 125 countries.
For further information, please visit：www.phchd.com
About Biomedical Division of PHC Corporation
Established in 1969, PHC Corporation is a subsidiary of PHC Holdings Corporation in Japan that develops, manufactures, sells, and services solutions across diabetes management, diagnostics and life sciences, as well as providing healthcare services. Committed to its corporate mission, “We contribute to the health of society through our diligent efforts to create healthcare solutions that have a positive impact and improve the lives of people,” the company offers value-added products and services to customers in over 125 countries. The Biomedical Division helps scientists and researchers in over 110 countries through its laboratory and medical support equipment and services including CO2 incubators and ultra-low temperature freezers.
For further information, please visit：www.phchd.com/global/biomedical/about-phcbi
Corporate Communications Group
PHC Holdings Corporation